Search Kailos website
Two Alabama-based organizations are partnering to find cures for common diseases that cause blindness for millions of people worldwide.
Huntsville, Ala. - October 2020 - Kailos Genetics, a CLIA-certified genetic sequencing company, announced they have entered into a partnership with Intermountain Healthcare to establish a pharmacogenetic testing platform for the healthcare network.
Huntsville, Ala. - October 2020 - Kailos Genetics announces the launch of Assure Sentinel, a first-of-its-kind workplace viral suppression program that tests organizations for COVID-19 on a frequent and recurring basis.
October 7, 2020
Breast cancer is the second most common cancer in women in the United States, and with one in every eight women developing some form of invasive breast cancer in their lifetime,1 many people know at least one woman that has been diagnosed with the disease.